Stem cell-based treatments against stroke: observations from human proof-of-concept studies and considerations regarding clinical applicability
Ischemic stroke remains a heavy burden for industrialized countries. The only causal therapy is the recanalization of occluded vessels via thrombolysis, which due to a narrow time window still can be offered only to a minority of patients. Since the majority of patients continues to exhibit neurolog...
Main Authors: | Thorsten Roland Doeppner, Dirk M. Hermann |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-10-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fncel.2014.00357/full |
Similar Items
-
Stem cells and progenitor cells in ischemic stroke – fashion or future?
by: Thorsten Roland Doeppner, et al.
Published: (2015-08-01) -
Studying post-stroke functional impairment after treatment with neural progenitor cells – an analysis of behavioral tests
by: Thorsten R. Doeppner, et al.
Published: (2014-10-01) -
Combination of Stem Cells and Rehabilitation Therapies for Ischemic Stroke
by: Reed Berlet, et al.
Published: (2021-09-01) -
Application of Stem Cells in Stroke: A Multifactorial Approach
by: Manisha Singh, et al.
Published: (2020-06-01) -
Adult Stem Cell Therapy for Stroke: Challenges and Progress
by: Oh Young Bang, et al.
Published: (2016-09-01)